Pharmacologic Treatment of Spasticity in Children and Adolescents with Cerebral Palsy

Authoring Organizations

Publication Month/Year

January 26, 2010

Last Updated Month/Year

January 4, 2024

Document Type


External Publication Status


Country of Publication


Document Objectives

To evaluate published evidence of efficacy and safety of pharmacologic treatments for childhood spasticity due to cerebral palsy.

Inclusion Criteria

Adolescent, Child

Health Care Settings

Ambulatory, Outpatient

Intended Users

Nurse, nurse practitioner, occupational therapist, physical therapist, physician, physician assistant, speech language pathologist



Diseases/Conditions (MeSH)

D002547 - Cerebral Palsy


movement disorder, cerebral palsy, muscle weakness, spasticity

Source Citation

Practice Parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. M. R. Delgado, D. Hirtz, M. Aisen, S. Ashwal, D. L. Fehlings, J. McLaughlin, L. A. Morrison, M. W. Shrader, A. Tilton, J. Vargus-Adams. Neurology Jan 2010, 74 (4) 336-343; DOI: 10.1212/WNL.0b013e3181cbcd2f

Supplemental Methodology Resources

Data Supplement, Data Supplement